BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei J, Gao X, Qin Y, Liu T, Kang Y. An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer. Onco Targets Ther 2020;13:12763-75. [PMID: 33363382 DOI: 10.2147/OTT.S287811] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Candido S, Tomasello B, Lavoro A, Falzone L, Gattuso G, Russo A, Paratore S, Mccubrey JA, Libra M. Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment. Front Cell Dev Biol 2022;10:945586. [DOI: 10.3389/fcell.2022.945586] [Reference Citation Analysis]
2 Yuan J, Liu T, Zhang Y. An Iron Metabolism-Related Gene Signature for the Prognosis of Colon Cancer. Front Cell Dev Biol 2022;9:786684. [DOI: 10.3389/fcell.2021.786684] [Reference Citation Analysis]
3 Guo X, Liang X, Wang Y, Cheng A, Zhang H, Qin C, Wang Z. Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer. Front Genet 2021;12:642608. [PMID: 34306002 DOI: 10.3389/fgene.2021.642608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zhu X, Zhou Y, Ou Y, Cheng Z, Han D, Chu Z, Pan S. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma. Aging (Albany NY) 2021;13:17655-72. [PMID: 34244461 DOI: 10.18632/aging.203257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]